Syros Pharmaceuticals' Corporate Minority - P2P Round

Syros Pharmaceuticals raised a round of funding on January 10, 2018. Investors include Incyte Corporation.

Syros Pharmaceuticals is a therapeutics company working in gene control to develop the treatment of cancer and other diseases. Syros' platform identifies the master switches for disease genes, opening…

Articles about Syros Pharmaceuticals' Corporate Minority - P2P Round: